Krystal Biotech, Inc.

KRYS · Healthcare · Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to…

Krystal Biotech, Inc. (KRYS), in the Healthcare sector, has 16 disclosed filings on Paydirt over the trailing twelve months from 6 corporate insiders: 0 purchases and 16 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Sep 4 and filed Sep 4. The most active filer was Krish S Krishnan with 8 filings.

Add to watchlist

Filings, ttm

0 buys · 16 sells

Traders, ttm

6 insiders

Volume, ttmiDollar value disclosed in the window

$104.5M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 4

Filed Sep 4

ADViAverage daily dollar volume

$140.4M

market data

Share price · 12M

$347 (+110.3%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $153.5M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Krish S Krishnan President and CEO 8 filings SK

Suma Krishnan President, R&D 8 filings KR

Kathryn Romano Chief Accounting Officer 3 filings DJ

Daniel Janney Director 2 filings DR

Dino A Rossi Director 2 filings JT

John Charles Thomas EVP, General Counsel 2 filings

Recent filings

Suma KrishnanSALE President, R&D $9.0M
25,000 sh across 13 lots
Exec Sep 4
Filed Sep 4 · 7:15 PM ET Krish S KrishnanSALE President and CEO $9.0M
25,000 sh across 13 lots
Exec Sep 4
Filed Sep 4 · 7:14 PM ET Dino A RossiSALE Director $8.2M
24,960 sh across 7 lots
Exec Aug 14
Filed Aug 14 · 6:22 PM ET John Charles ThomasSALE EVP, General Counsel $347K
1,000 sh × $347.27
Exec Jun 25
Filed Jun 26 · 5:30 PM ET Krish S KrishnanSALE President and CEO $7.5M
24,464 sh across 8 lots
Exec Jun 4
Filed Jun 5 · 5:30 PM ET Suma KrishnanSALE President, R&D $7.5M
24,193 sh across 8 lots
Exec Jun 4
Filed Jun 5 · 5:30 PM ET John Charles ThomasSALE EVP, General Counsel $194K
642 sh × $302.03
Exec May 26
Filed May 27 · 5:30 PM ET Krish S KrishnanSALE President and CEO $6.6M
25,000 sh across 10 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Suma KrishnanSALE President, R&D $6.6M
25,000 sh across 10 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Daniel JanneySALE Director $3.3M
11,803 sh across 2 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET Kathryn RomanoSALE Chief Accounting Officer $201K
750 sh × $267.60
Exec Mar 2
Filed Mar 3 · 5:30 PM ET Daniel JanneySALE Director $16.0M
59,729 sh across 18 lots
Exec Feb 24
Filed Feb 26 · 5:30 PM ET Dino A RossiSALE Director $5.0M
18,950 sh across 2 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET Kathryn RomanoSALE Chief Accounting Officer $3.4M
12,404 sh across 6 lots
Exec Feb 9
Filed Feb 11 · 5:30 PM ET Krish S KrishnanSALE President and CEO $10.9M
49,456 sh across 14 lots
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET Suma KrishnanSALE President, R&D $10.9M
49,456 sh across 14 lots
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET Krish S KrishnanSALE President and CEO $5.4M
35,773 sh across 8 lots
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET Suma KrishnanSALE President, R&D $5.4M
35,773 sh across 8 lots
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET Krish S KrishnanSALE President and CEO $2.0M
13,127 sh across 2 lots
Exec Jul 10 2025
Filed Jul 11 2025 · 5:30 PM ET Suma KrishnanSALE President, R&D $2.0M
13,127 sh across 2 lots
Exec Jul 10 2025
Filed Jul 11 2025 · 5:30 PM ET Krish S KrishnanSALE President and CEO $8.9M
50,000 sh across 10 lots
Exec Mar 13 2025
Filed Mar 13 2025 · 5:30 PM ET Suma KrishnanSALE President, R&D $8.9M
50,000 sh across 10 lots
Exec Mar 13 2025
Filed Mar 13 2025 · 5:30 PM ET Kathryn RomanoSALE Chief Accounting Officer $131K
750 sh × $175.22
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET Krish S KrishnanSALE President and CEO $8.2M
49,800 sh across 16 lots
Exec Dec 13 2024
Filed Dec 13 2024 · 5:30 PM ET Suma KrishnanSALE President, R&D $8.2M
49,800 sh across 16 lots
Exec Dec 13 2024
Filed Dec 13 2024 · 5:30 PM ET